| Company/Division name | MilliporeSigma |
| Parent company | Merck KGaA |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 50 |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2022 |
| Capital investment ($): | 65 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Veron |
| State(s) reshored to: | WI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | highly potent APIs (HPAPIs) |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |
| What domestic positive factors made reshoring more attractive? | Lean/other business process improvement techniques |
